Elimination of measles by 2024: achievements and challenges

Authors

  • Sabrina Afrin Department of Microbiology, Popular Medical College, Dhaka, Bangladesh
  • Kazi Taib Mamun Infectious Disease Division, icddr,b, Dhaka, Bangladesh
  • Nabeela Mahboob 1Department of Microbiology, Popular Medical College, Dhaka, Bangladesh
  • Hasina Iqbal Department of Microbiology, Popular Medical College, Dhaka, Bangladesh
  • Hasnatul Jannat Department of Microbiology, Popular Medical College, Dhaka, Bangladesh

Keywords:

measles, infectious agent

Abstract

Measles is an infectious agent of viral origin with exceedingly high rate of transmissibility contributing to very high morbidity and mortality rates especially among children. Although measles is extremely infectious, control strategies of this virus used to be recognized as one of the most successful public health interventions ever undertaken. However, despite being vaccine-preventable disease measles has encountered an enormous resurgence as the rate of measles vaccination has declined and in many countries vaccination targets remain unmet and measles continues to claim hundreds of thousands of lives each year. This review discusses the reasons of the re-emergence of measles, the present global and Bangladesh situation and strategies that have been undertaken to combat this killer disease to eliminate measles globally by the year 2024.

Ibrahim Med. Coll. J. 2020; 14(1): 53-58

Downloads

Download data is not yet available.
Abstract
458
PDF
642

Downloads

Published

2020-06-09

How to Cite

Afrin, S., Mamun, K. T., Mahboob, N., Iqbal, H., & Jannat, H. (2020). Elimination of measles by 2024: achievements and challenges. IMC Journal of Medical Science, 14(1), 53–58. Retrieved from https://banglajol.info/index.php/IMCJMS/article/view/47456

Issue

Vol. 14 No. 1 (2020)

Section

Review Article

License

Authors who publish in IMCJMS agree to the following terms that:

  1. Authors retain copyright and grant IMCJMS the right of first publication of the work.

  2. Creative Commons Licence
    Articles in IMCJMS are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.